Displaying drugs 14851 - 14875 of 15546 in total
Carlecortemcel-L
Investigational
PBCAR269A
Investigational
PBCAR20A
Investigational
P-2045 Re-188
Investigational
ALM201
ALM201 is an anti-angiogenic synthetic peptide identified from the endogenous human protein, FKBPL. It is being investigated in the treatment of various cancers.
Investigational
KAb201
Investigational
hu3S193
Investigational
Pritumumab
Investigational
Tamrintamab pamozirine
Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
Investigational
JCAR014
Investigational
Letetresgene autoleucel
Investigational
M-032
Investigational
Zevorcabtagene autoleucel
Investigational
Galinpepimut-S
Investigational
ST101 peptide
ST101 is a cell-penetrating peptide that disrupts the protein-protein interactions driving ATF5-regulated gene transcription.
Investigational
ONCOS-102
Investigational
GVAX
GVAX is a granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transfected tumor cell vaccine.
Investigational
OriCar-017
Investigational
Pelareorep
Investigational
G305
G305 is a recombinant NY-ESO-1 protein plus glucopyranosyl lipid A (GLA) in a stable emulsion (SE). G305 is an active component of CMB305 along with LV305.
Investigational
Hepcortespenlisimut-L
Investigational
Leukocyte interleukin
Investigational
Prexigebersen
Investigational
Displaying drugs 14851 - 14875 of 15546 in total